KEWAUNEE SCIENTIFIC CP(NASDAQ:KEQU) stock Fundamental Analysis

Fundamental Rating

KEQU gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. KEQU is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. KEQU has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

KEQU had positive earnings in the past year.

In the past year KEQU had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.

In multiple years KEQU reported negative operating cash flow during the last 5 years.

1.2 Ratios

With an excellent Return On Assets value of 13.94%, KEQU belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.

KEQU's Return On Equity of 31.60% is amongst the best of the industry. KEQU outperforms 98.42% of its industry peers.

Looking at the Return On Invested Capital, with a value of 13.09%, KEQU belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	13.94%
ROE	31.6%
ROIC	13.09%

ROA(3y)3.12%

ROA(5y)-0.07%

ROE(3y)6.34%

ROE(5y)-0.44%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

KEQU's Profit Margin of 9.39% is amongst the best of the industry. KEQU outperforms 83.16% of its industry peers.

KEQU's Profit Margin has improved in the last couple of years.

Looking at the Operating Margin, with a value of 8.20%, KEQU is in the better half of the industry, outperforming 76.32% of the companies in the same industry.

In the last couple of years the Operating Margin of KEQU has grown nicely.

KEQU's Gross Margin of 26.60% is on the low side compared to the rest of the industry. KEQU is outperformed by 78.42% of its industry peers.

KEQU's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	8.2%
PM (TTM)	9.39%
GM	26.6%

OM growth 3YN/A

OM growth 5Y44.33%

PM growth 3YN/A

PM growth 5Y55.17%

GM growth 3Y16.23%

GM growth 5Y8.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.

KEQU has more shares outstanding than it did 1 year ago.

KEQU has more shares outstanding than it did 5 years ago.

KEQU has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.13 indicates that KEQU is not in any danger for bankruptcy at the moment.

With a decent Altman-Z score value of 4.13, KEQU is doing good in the industry, outperforming 75.26% of the companies in the same industry.

The Debt to FCF ratio of KEQU is 1.82, which is an excellent value as it means it would take KEQU, only 1.82 years of fcf income to pay off all of its debts.

KEQU has a better Debt to FCF ratio (1.82) than 89.47% of its industry peers.

A Debt/Equity ratio of 0.47 indicates that KEQU is not too dependend on debt financing.

KEQU has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.47
Debt/FCF	1.82
Altman-Z	4.13

ROIC/WACC1.54

WACC8.49%

2.3 Liquidity

KEQU has a Current Ratio of 2.64. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.

KEQU has a Current ratio (2.64) which is comparable to the rest of the industry.

A Quick Ratio of 2.13 indicates that KEQU has no problem at all paying its short term obligations.

With a Quick ratio value of 2.13, KEQU perfoms like the industry average, outperforming 50.53% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.64
Quick Ratio	2.13

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KEQU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 167.22%, which is quite impressive.

The Earnings Per Share has been growing by 64.49% on average over the past years. This is a very strong growth

The Revenue has decreased by -7.18% in the past year.

Measured over the past years, KEQU shows a small growth in Revenue. The Revenue has been growing by 6.81% on average per year.

EPS 1Y (TTM)167.22%

EPS 3YN/A

EPS 5Y64.49%

EPS Q2Q%8.51%

Revenue 1Y (TTM)-7.18%

Revenue growth 3Y11.37%

Revenue growth 5Y6.81%

Sales Q2Q%-5.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.04 indicates a reasonable valuation of KEQU.

97.89% of the companies in the same industry are more expensive than KEQU, based on the Price/Earnings ratio.

KEQU is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	8.04
Fwd PE	N/A

4.2 Price Multiples

96.84% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.

KEQU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KEQU is cheaper than 98.42% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	9.18
EV/EBITDA	7.53

4.3 Compensation for Growth

The decent profitability rating of KEQU may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.12

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for KEQU!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (3/7/2025, 8:00:02 PM)

Premarket: 52.35 +1.6 (+3.15%)

50.75

+1.37 (+2.77%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)12-12 2024-12-12/amc

Earnings (Next)03-12 2025-03-12/amc

Inst Owners44.09%

Inst Owner Change12.68%

Ins Owners16.11%

Ins Owner Change-2.44%

Market Cap145.65M

Analysts82.86

Price TargetN/A

Short Float %2.86%

Short Ratio2.23

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	8.04
Fwd PE	N/A
P/S	0.73
P/FCF	9.18
P/OCF	7.96
P/B	2.46
P/tB	2.46
EV/EBITDA	7.53

EPS(TTM)6.31

EY12.43%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)5.53

FCFY10.9%

OCF(TTM)6.37

OCFY12.56%

SpS69.56

BVpS20.67

TBVpS20.67

PEG (NY)N/A

PEG (5Y)0.12

Profitability

		Industry Rank	Sector Rank
ROA	13.94%
ROE	31.6%
ROCE	16.71%
ROIC	13.09%
ROICexc	17.76%
ROICexgc	17.76%
OM	8.2%
PM (TTM)	9.39%
GM	26.6%
FCFM	7.95%

ROA(3y)3.12%

ROA(5y)-0.07%

ROE(3y)6.34%

ROE(5y)-0.44%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y44.49%

ROICexc growth 3YN/A

ROICexc growth 5Y44.49%

OM growth 3YN/A

OM growth 5Y44.33%

PM growth 3YN/A

PM growth 5Y55.17%

GM growth 3Y16.23%

GM growth 5Y8.16%

F-Score6

Asset Turnover1.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0.47
Debt/FCF	1.82
Debt/EBITDA	1.43
Cap/Depr	74.13%
Cap/Sales	1.21%
Interest Coverage	250
Cash Conversion	93.15%
Profit Quality	84.66%
Current Ratio	2.64
Quick Ratio	2.13
Altman-Z	4.13

F-Score6

WACC8.49%

ROIC/WACC1.54

Cap/Depr(3y)117.83%

Cap/Depr(5y)107.18%

Cap/Sales(3y)1.72%

Cap/Sales(5y)1.69%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)167.22%

EPS 3YN/A

EPS 5Y64.49%

EPS Q2Q%8.51%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-7.18%

Revenue growth 3Y11.37%

Revenue growth 5Y6.81%

Sales Q2Q%-5.31%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y17.63%

EBIT growth 3YN/A

EBIT growth 5Y54.15%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y468.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y858.8%

OCF growth 3Y178.06%

OCF growth 5Y51.03%

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens